This compound is a deuterium-labeled carbamate derivative used as a pharmaceutical reference standard or active pharmaceutical ingredient. It is characterized by a high degree of polar surface area and multiple hydrogen bond donor and acceptor sites, reflecting its carbamate functional groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing (+/-)-Carisoprodol-d7 (iso-propyl-d7)?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
2-(2,5-Difluorophenyl)pyrrolidine, (R)-
pharmaceutical raw material
Calteridol calcium
pharmaceutical raw material
4-[3-Phenyl-5-(trideuteriomethyl)-1,2-oxazol-4-yl]benzenesulfonamide
pharmaceutical raw material
Trimetazidine-d8 Dihydrochloride
pharmaceutical raw material
Carisoprodol
pharmaceutical raw material
[2-(carbamoyloxymethyl)-2-methylpentyl] N-(1,1,1,2,3,3,3-heptadeuteriopropan-2-yl)carbamate
OFZCIYFFPZCNJE-DNDFCSDFSA-N
[2H]C([2H])([2H])C([2H])(C([2H])([2H])[2H])NC(=O)OCC(C)(CCC)COC(=O)N
—
Sourcing (+/-)-Carisoprodol-d7 (iso-propyl-d7)?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.